Healthcare provider profile · identity verified

Prasanna Malla, MD

Internal Medicine · ENGLEWOOD, NJ · NPI 1629319157

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	348	136
Amlodipine Besylate	Amlodipine Besylate	267	101
Levothyroxine Sodium	Levothyroxine Sodium	231	72
Lisinopril	Lisinopril	192	70
Losartan Potassium	Losartan Potassium	168	60
Hydrochlorothiazide	Hydrochlorothiazide	137	55
Albuterol Sulfate Hfa	Albuterol Sulfate	131	69
Fluticasone Propionate	Fluticasone Propionate	126	56
Omeprazole	Omeprazole	117	40
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	114	30
Metoprolol Tartrate	Metoprolol Tartrate	103	38
Famotidine	Famotidine	101	41
Alendronate Sodium	Alendronate Sodium	98	33
Furosemide	Furosemide	86	33
Metformin Hcl Er	Metformin Hcl	78	36
Atenolol	Atenolol	76	29
Gabapentin	Gabapentin	73	28
Metoprolol Succinate	Metoprolol Succinate	73	22
Pregabalin	Pregabalin	72	24
Tamsulosin Hcl	Tamsulosin Hcl	71	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	70	26
Ibuprofen	Ibuprofen	69	38
Trazodone Hcl	Trazodone Hcl	68	23
Pantoprazole Sodium	Pantoprazole Sodium	67	34
Allopurinol	Allopurinol	64	24
Simvastatin	Simvastatin	61	23
Alvesco	Ciclesonide	56	29
Glipizide	Glipizide	55	23
Metformin Hcl	Metformin Hcl	53	24
Baclofen	Baclofen	46	21
Fluoxetine Hcl	Fluoxetine Hcl	46	15
Potassium Chloride	Potassium Chloride	46	21
Hydrocortisone	Hydrocortisone	44	26
Prednisone	Prednisone	43	34
Fluocinonide	Fluocinonide	39	22
Lovastatin	Lovastatin	38	14
Ozempic	Semaglutide	36	suppressed
Acyclovir	Acyclovir	35	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	34	24
Pravastatin Sodium	Pravastatin Sodium	32	12
Hydralazine Hcl	Hydralazine Hcl	31	13
Wixela Inhub	Fluticasone Propion/Salmeterol	31	suppressed
Carvedilol	Carvedilol	30	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	11
Clopidogrel	Clopidogrel Bisulfate	29	14
Acetaminophen-Codeine	Acetaminophen With Codeine	27	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	12
Methocarbamol	Methocarbamol	27	suppressed
Sertraline Hcl	Sertraline Hcl	27	12
Lorazepam	Lorazepam	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	12
Propranolol Hcl	Propranolol Hcl	26	11
Tramadol Hcl	Tramadol Hcl	26	suppressed
Finasteride	Finasteride	25	suppressed
Lactulose	Lactulose	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Glipizide Er	Glipizide	20	suppressed
Nystatin	Nystatin	20	12
Cefadroxil	Cefadroxil	19	19
Eliquis	Apixaban	19	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	19	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	19	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Duloxetine Hcl	Duloxetine Hcl	17	suppressed
Rizatriptan	Rizatriptan Benzoate	17	suppressed
Terazosin Hcl	Terazosin Hcl	17	suppressed
Jardiance	Empagliflozin	16	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	16	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	15	14
Doxycycline Monohydrate	Doxycycline Monohydrate	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	15	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	15	suppressed
Temazepam	Temazepam	15	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	15	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	13	13
Alprazolam	Alprazolam	13	suppressed
Breyna	Budesonide/Formoterol Fumarate	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Humulin N	Insulin Nph Human Isophane	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Ondansetron Odt	Ondansetron	12	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Methylphenidate Er	Methylphenidate Hcl	11	suppressed
Sucralfate	Sucralfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error